New HIPAA Rule Enhances Privacy Protections For Reproductive Health Information

OG
Outside GC

Contributor

OGC is a unique law firm that offers the relationship and experience of a traditional law firm with the cost savings and speed of an ALSP. By combining top-notch legal talent and significant business acumen, we deliver the value and efficiency of an in-house lawyer, without adding to our client’s headcount or sacrificing quality.
On April 26, 2024, the Office of Civil Rights (OCR) within the Department of Health and Human Services (HHS) announced a significant update...
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

On April 26, 2024, the Office of Civil Rights (OCR) within the Department of Health and Human Services (HHS) announced a significant update to the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule. This new Final Rule, which took effect on June 25, 2024, aims to strengthen the privacy of reproductive health care information in response to the heightened concerns following the Supreme Court's 2022 decision in Dobbs v. Jackson Women's Health Organization.

The Dobbs decision, which resulted in 21 states imposing abortion bans and other restrictions on reproductive freedom, sparked fears about the potential misuse of reproductive health information. In response, the OCR's Final Rule introduces critical amendments to the HIPAA Privacy Rule, prohibiting covered entities and their business associates from using or disclosing protected health information (PHI) for criminal, civil, or administrative investigations related to lawful reproductive health care. Compliance with the Final Rule is required by December 22, 2024.

Key Provisions of the Final Rule

  • Purpose-Based Prohibition
    The new regulations specifically prohibit using or disclosing PHI for the purpose of conducting investigations or imposing liability on individuals seeking, obtaining, providing, or facilitating lawful reproductive health care.
  • Attestation Requirement
    To ensure compliance, covered entities must obtain a valid attestation from anyone requesting reproductive health information, affirming that the use or disclosure is not for a prohibited purpose. This attestation must be clear, in plain language, and separate from other documents.
  • Updating the Notice of Privacy Practices (NPP)
    HIPAA-covered entities are required to revise their NPPs to incorporate detailed descriptions of the new protections, including examples of prohibited uses and disclosures, and information about the attestation requirement.
  • Compliance and Enforcement
    The Final Rule mandates compliance by December 22, 2024, with specific provisions for updating NPPs requiring compliance by February 16, 2026. Entities failing to adhere to these new requirements may face severe civil and criminal penalties.
  • Preparing for Implementation
    Healthcare providers, health plans, and business associates can begin preparing for these changes by updating their policies, training staff, and ensuring all requests for reproductive health information are carefully reviewed for compliance. The OCR has committed to providing additional resources to assist entities in this transition.

Conclusion

The OCR's Final Rule represents a significant step in safeguarding the privacy of reproductive health information. By preventing the misuse of PHI in investigations and legal proceedings related to lawful reproductive health care, these new regulations aim to foster trust between patients and healthcare providers and ensure continued access to essential health services.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More